Related Experiment Video
Updated: May 22, 2026
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Management of non-small cell lung cancer with oligometastasis
Liza C Villaruz1, Gregory J Kubicek, Mark A Socinski
1University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. villaruzl@upmc.edu
Abstract:
Patients with oligometastatic Non-Small Cell Lung Cancer (NSCLC) present a potential opportunity for curative therapy; however, the challenge remains the definitive treatment of their localized disease and ablation of their limited overt metastatic sites of disease. In selecting patients with oligometastatic NSCLC for definitive therapy, proper staging through radiographic studies, including PET and brain MRI, and the pathologic staging of the mediastinal lymph nodes and potential sites of metastatic disease, are critical. With that in mind, the available literature suggests that in highly selected patients with solitary metastases to the brain, adrenals and other organs, long term survival may be achieved with combined definitive therapy of both the primary lung tumor and the solitary metastatic site.
Insights
Curative therapy is possible for select patients with oligometastatic Non-Small Cell Lung Cancer (NSCLC). Definitive treatment of the primary tumor and solitary metastases may lead to long-term survival.
Area of Science:
- Oncology
- Medical Imaging
Background:
- Oligometastatic Non-Small Cell Lung Cancer (NSCLC) presents a treatment challenge.
- Localized disease and limited metastatic sites offer potential for curative therapy.
Purpose of the Study:
- To explore curative treatment strategies for oligometastatic NSCLC.
- To identify critical factors for selecting patients for definitive therapy.
Main Methods:
- Comprehensive staging including radiographic studies (PET, brain MRI).
- Pathologic staging of mediastinal lymph nodes and metastatic sites.
Main Results:
- Literature suggests long-term survival in highly selected patients.
- Combined definitive therapy of primary tumor and solitary metastasis is effective.
Conclusions:
- Proper staging is crucial for patient selection in oligometastatic NSCLC.
- Curative intent is feasible for select patients with solitary metastases.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11:17Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026